home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Windtree Therapeutics, Inc. - Common Stock (NQ:WINT)

0.1100 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Windtree Therapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Bed Bath & Beyond Is Trading Higher By 12%; Here Are 26 Stocks Moving Premarket ↗

August 24, 2022

Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 25.2% to $0.54 in pre-market trading. Bird secured permit extensions and expanded to new U.S. cities.

Via Benzinga

Why XPeng Shares Traded Lower By Around 11%; Here Are 77 Biggest Movers From Yesterday ↗

August 24, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 23, 2022

Gainers

Via Benzinga

Dow Drops Over 100 Points; Aerie Pharmaceuticals Shares Spike Higher ↗

August 23, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones dropping over 100 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 23, 2022

Via Benzinga

Why Is Windtree Therapeutics (WINT) Stock Up 50%? ↗

August 23, 2022

Windtree Therapeutics (WINT) is one of the biggest stock movers on Tuesday after announcing a new global licensing agreement for AEROSURF.

Via InvestorPlace

Nasdaq Turns Lower; Crude Oil Rises Sharply ↗

August 23, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite turning negative on Tuesday.

Via Benzinga

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

Here's Why Windtree Therapeutics Shares Are Popping Off Today ↗

August 23, 2022

Windtree Therapeutics Inc (NASDAQ: WINT) shares are trading higher by 63.98% to $0.74 after the company announced it has entered into a global licensing agreement for the development and...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 23, 2022

Via Benzinga

Windtree Therapeutics: Q2 Earnings Insights ↗

August 11, 2022

Windtree Therapeutics (NASDAQ:WINT) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Windtree...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

July 27, 2022

Wednesday saw 83 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 12, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

May 26, 2022

On Thursday, 94 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 25, 2022

On Wednesday, 215 companies set new 52-week lows.

Via Benzinga

25 Stocks Moving in Tuesday's Pre-Market Session ↗

May 24, 2022

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 136.4% to $1.43 in pre-market trading. BOQI International recently posted a Q1 loss of $0.27 per share.

Via Benzinga

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗

May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 25, 2022

On Monday, 721 companies achieved new lows for the year.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 21, 2022

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 22, 2022

Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle...

Via Benzinga

Windtree Therapeutics Stock Is Trading Higher: Here's Why ↗

April 20, 2022

Windtree Therapeutics Inc (NASDAQ: WINT) shares are trading higher Wednesday after the company announced topline results from the Phase 2 SEISMiC study of istaroxime in early...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study ↗

April 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 20, 2022: Procter & Gamble, Lululemon, Netflix, And More ↗

April 20, 2022

Benzinga’s “Daily Brief On Trending Tickers” features the top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 20, 2022

Gainers Windtree Therapeutics (NASDAQ:WINT) stock rose 40.0% to $1.4 during Wednesday's pre-market session. The company's market cap stands at $39.8 million....

Via Benzinga

Windtree Reveals Encouraging Data From Istaroxime Study In Early Cardiogenic Shock ↗

April 20, 2022

Windtree Therapeutics Inc (NASDAQ: WINT) has announced positive primary results with istaroxime in rapidly raising systolic blood pressure. Istaroxime is a first-in-class dual mechanism therapy...

Via Benzinga

Windtree Posts Mid-Stage Study Data On Lucinactant For COVID-19-Associated Respiratory Distress ↗

March 22, 2022

Windtree Therapeutics Inc (NASDAQ: WINT)

Via Benzinga

Windtree Therapeutics Concludes Enrollment In Mid-Stage Cardiogenic Shock Study, Data Expected In April ↗

March 15, 2022

Windtree Therapeutics Inc (NASDAQ: WINT) has

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com